Latest Point-of-care testing Stories
CHELMSFORD, Mass., July 16 /PRNewswire/ -- Magellan Biosciences, an emerging leader in clinical diagnostics, will feature a variety of automated systems and diagnostic tests designed to help doctors make faster, more-informed treatment decisions in Booth 3244 at the 2009 AACC/ASCLS Clinical Lab Expo. Products on view will include TREK's blood-culture systems and susceptibility products; Dynex's automated ELISA assay systems; ESA's FDA-cleared Vitamin D Test; and the LeadCare(R) II...
Agreement with Medical Automation Systems, Inc. Will Add RALS(R)-Plus Module to Company's Hemoglobin and Glucose Handheld Devices MADISON, N.J., June 22 /PRNewswire-FirstCall/ -- HemoCue Inc., the U.S. point-of-care testing distribution subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has signed an agreement with Medical Automation Systems, Inc. (MAS) for the development of a RALS(R)-Plus module for the HemoCue 201 DM analyzer whole blood systems for...
Agreement to Distribute MEC HbA1c Test To Provide Physicians in U.S. and Europe With Fast, Accurate Near-Patient Test for Diabetes Monitoring MADISON, N.J., June 2 /PRNewswire-FirstCall/ -- HemoCue AB, an international company in the field of point-of-care testing and a subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has signed an agreement with MEC Dynamics Corp (MEC) for the exclusive distribution of the Avie(TM) A1c point-of-care test in the United...
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. Point of Care Diagnostic Testing World Markets http://www.reportlinker.com/p096375/Point-of-Care-Diagnostic-Testing-World-Markets.html The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines these clinical measurement devices and their...
INDIANAPOLIS, July 28 /PRNewswire/ -- Roche Diagnostics and Response Biomedical have entered into a partnership that will allow Roche to market the first line of cardiovascular tests for Response Biomedical's new point-of-care platform. The platform, the RAMP(R) 200 (Rapid Analyte Measurement Platform), is based on RAMP technology that is already used in laboratories worldwide for West Nile Virus, biodefense tests and the recently FDA-cleared RAMP Flu A/B Test. The RAMP cardiovascular...
According to a new InteLab Corporation industry report distributed by Life Science Intelligence (LSI), the worldwide Point-of-Care Testing (POCT) market is outpacing the overall In Vitro Diagnostics market at a significant rate. Several companies are capitalizing on this growth, including Inverness, Biosite, Cholestech, and HemoSense. Each of these companies has recently been involved in acquisitions, further demonstrating the growing value of suppliers in this market. The report,...
NEW YORK, Feb. 15 /PRNewswire/ -- As the global call for increased usage of near-patient diagnostic testing escalates, the market for lateral flow point-of-care (LF-POC) tests for everything from cardiac markers and cholesterol to diabetes and infectious diseases continues to rise at a healthy rate, with sales expected to surpass $2.7 billion by 2010, according to Lateral Flow Technology and the Future of Point of Care Diagnostics, a new study from medical market research firm Kalorama...
